At a meeting of the Board of Directors of Kiromic BioPharma, Inc. held on January 27, 2022, the Board approved the appointment of Mr. Francis (Frank) X. Tirelli as a director of the Company effective on January 28, 2022, the appointment of Dr. Karen Reeves as a director of the Company effective on February 14, 2022 and the appointment of Pietro Bersani as Interim Chief Executive Officer effective immediately. Mr. Tirelli has served as Chairman of Professional Services at alliantgroup, LP since September 2018. Since September 2018, Mr. Tirelli has also served on the Strategic Advisory Board of alliantgroup LP.

Dr. Reeves has served as President and Chief Medical Officer of AZTherapies, Inc. since September 2017.